Header Logo

Connection

Christopher Seder to Hypoglycemic Agents

This is a "connection" page, showing publications Christopher Seder has written about Hypoglycemic Agents.
Connection Strength

0.542
  1. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2016 Jul; 152(1):55-61.e1.
    View in: PubMed
    Score: 0.542
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.